Skip to main content
OpenTrials

Clinical trial condition

Recurrence

Explore clinical trials studying Recurrence. Study availability and eligibility vary by location and protocol.

2,310 public trials 520 recruiting studies
Refine in advanced search Browse all conditions

Recurrence trial results

Recruiting

A Study of YL201 in Combination With Toripalimab and With or Without Cisplatin in Nasopharyngeal Carcinoma.

NCT07258979

Conditions
Carcinoma, Disease Attributes, Head and Neck Neoplasms, +16 more
Locations
  • Chongqing University Cancer Hospital Chongqing, Chongqing Municipality, China
  • Fujian Cancer Hospital Fuzhou, Fujian, China
  • The First Affiliated Hospital of Xiamen University Xiamen, Fujian, China
  • Zhangzhou Municiple Hospital of Fujian Province Zhangzhou, Fujian, China
View all 20 locations
View Trial Details
Recruiting

Study to Evaluate the Efficacy of Axicabtagene Ciloleucel in Patients With Late Relapse of Diffuse Large B-Cell Lymphoma

NCT07254754

Conditions
Diffuse Large B-cell Lymphoma, Disease Attributes, Hemic and Lymphatic Diseases, +13 more
Locations
  • Complejo Hospitalario Universitario A Coruña A Coruña, Spain
  • Hospital Universitario Son Espases Palma de Mallorca, Balearic Islands, Spain
  • Hospital Universitario Marqués de Valdecilla Santander, Cantabria, Spain
  • Hospital Universitario de Salamanca Salamanca, Castille and León, Spain
View all 15 locations
View Trial Details
Recruiting

A National Study Examining the Most Effective Drainage Method After Burr Hole Evacuation of Chronic Subdural Hematoma

NCT06621407

Conditions
Brain Diseases, Cardiovascular Diseases, Central Nervous System Diseases, +23 more
Locations
  • Department of Neurosurgery, Aalborg University Hospital Aalborg, Denmark
  • Department of Neurosurgery, Aarhus University Hospital Aarhus, Denmark
  • Department of Neurosurgery, Copenhagen University Hospital Rigshospitalet Copenhagen, Denmark
  • Department of Neurosurgery, Odense University Hospital Odense, Denmark
View Trial Details
Recruiting

A Study to Find Out How Safe REGN5668 is and How Well it Works In Adult Women When Given With Either Cemiplimab, or Cemiplimab + Fianlimab, or Ubamatamab

NCT04590326

Conditions
Adnexal Diseases, Disease Attributes, Endocrine Gland Neoplasms, +25 more
Locations
  • City of Hope Comprehensive Cancer Center Duarte, California, United States
  • The City of Hope Orange County Lennar Foundation Cancer Center Irvine, California, United States
  • Chao Family Comprehensive Cancer Center Orange, California, United States
  • H. Lee Moffitt Cancer Center Tampa, Florida, United States
View all 24 locations
View Trial Details

Related conditions